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Abstract
Background: Optical Enhancement technology (OE) com-
bines bandwidth-limited light and image enhancement pro-
cessing technology to enhance subtle mucosal and vascular 
details. This is the first study assessing the new technology 
for the diagnosis of gastroesophageal reflux disease (GERD). 
Patients and Methods: Consecutive patients with GERD and 
controls were prospectively included. The distal esophagus 
was examined in all quadrants with high definition white-
light endoscopy (HD-WLE) followed by OE and biopsies for 
histopathological analysis. Features observed only by OE 
were compared between controls and patients with GERD. 
Results: A total of 100 areas were evaluated. About 56% of 
patients had a diagnosis of GERD. The mean age of patients 
was 53 years (range 27–89 years), 60% were female. Com-
pared to controls, patients with diagnosis of GERD showed 
significantly more often tortuosity (p = 0.042), dilation (p = 
0.0003), and increased number (p = 0.001) of intrapapillary 
capillary loops (IPCLs). In addition, increased vascularity and 
mucosal breaks were significantly more often found in pa-
tients with GERD as compared to controls (p < 0.05). On mul-
tivariate analysis, increased number and dilation of IPCL 
were the best predictors of GERD. Conclusions: The newly 
introduced OE technology significantly improves the diag-
nosis of GERD compared to HD-WLE. The results should be 
confirmed in a multicenter trial.
© 2018 S. Karger AG, Basel
Introduction
Gastroesophageal reflux disease (GERD) is one of the 
most common diseases of the esophagus, with an increas-
ing incidence worldwide [1]. Its prevalence varies from 18 
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to 27% in the USA and 8 to 26% in Europe [2]. GERD com-
prises of 3 entities, erosive reflux disease (ERD), non-ero-
sive reflux disease (NERD), and Barrett’s esophagus [3]. 
The latter has been established as a precancerous condi-
tion requiring extensive surveillance. Diagnosis of GERD 
is based on clinical, endoscopic, histologic, and functional 
parameters [4]. Of note, up to 70% of patients suffering 
from reflux-like symptoms (e.g., heartburn, regurgitation) 
do not show any endoscopic abnormalities [5] and are 
considered as NERD patients. Recent data have shown 
that advanced endoscopic imaging techniques, including 
Narrow Band Imaging (NBI; Olympus, Tokyo, Japan) and 
i-scan (Pentax Medical, Tokyo, Japan) allow for endoscop-
ic visualization of distinct mucosal abnormalities in pa-
tients with NERD, thereby potentially allowing for a better 
diagnosis and therapy of those patients [6–9]. 
Most recently, the Optical Enhancement (OE; Pentax 
Medical, Tokyo, Japan) technology was introduced as a 
novel technique allowing exact visualization of the mu-
cosal surface pattern morphology. OE combines optical 
and digital chromoendoscopy techniques allowing for 
both visualization of the mucosal surface pattern and 
mucosal vascular pattern morphology [10]. In particular, 
OE uses band-limited light emission at 415, 540, and 
570 nm connecting the peaks of hemoglobin absorption 
spectrum as well as red light emission to increase the 
overall brightness of the image. Thus, OE enables the vi-
sualization of blood vessels and provides better illumina-
tion, especially in large lumen organs such as the stom-
ach and the colon. This is the main difference of OE com-
pared to other advanced imaging technologies that also 
narrow the red light such as NBI. Yet, no data are avail-
able on the potential of the novel OE technology for the 
diagnosis of GERD.
Therefore, the aim of the current study is to prospec-
tively evaluate the diagnostic efficacy of the newly intro-
duced OE technology as compared to high-definition 
white-light endoscopy (WLE) in patients suffering from 
GERD.
Materials and Methods 
Endoscopic System and Principle
A video processor with OE technology (Pentax, Tokyo, Japan) 
was used in this study. For OE, the baseline transmittance between 
the peaks of the hemoglobin absorption spectrum is raised, result-
ing in an improved visualization of microvessels with a sufficient 
amount of light. The principle is based on optical filters achieving 
higher overall transmittance by connecting the peaks of the hemo-
globin absorption spectrum (415, 540, and 570 nm), thereby creat-
ing a continuous wavelength spectrum.
Patients
A total of 25 patients were prospectively included in a time pe-
riod of 12 months. In 14 patients, diagnosis of GERD [4] was made 
based on clinical information (Reflux Disease Questionnaire Score 
> 3, [11]) or histopathological workout at the time of recruitment. 
About 11 patients without any GERD symptoms served as control 
patients. All patients gave their written consent and received 
esophagogastroduodenoscopy with the new OE technology. Pa-
tients with known esophageal disorders other than GERD were 
excluded from the study. The study was approved by the local eth-
ics committee.
Endoscopic Procedure
All procedures in this study were performed using the i10 en-
doscope and the Optivista video processor with OE technology. 
Patients underwent conscious sedation and received cardiopul-
monary monitoring during the examination. All patients were ini-
tially examined in all quadrants by high-definition WLE. The dis-
tal esophagus was consequently evaluated with OE. The following 
features were examined in all patients, as previously described [12–
14]: (a) intraepithelial papillary capillary loop (IPCL) tortuosity, 
(b) IPCL dilation, (c) IPCL quantity, (d) vascularity, and (e) mu-
cosal breaks.
Normal IPCLs were recognized endoscopically as hairpin-like 
structures with small diameter. Tortuosity was defined by the pres-
ence of corkscrewing or twisted nature of individual IPCLs. Dilata-
tion of IPCLs was recognized by their increased size or caliber, 
whereas increment was recognized as an increase in the number of 
IPCLs in individual fields. Presence of micro erosions was detected 
as mucosal breaks not visible at standard endoscopy. Increased 
vascularity at the squamocolumnar junction were noted as being 
present or absent.
Statistical Analysis
Results are expressed as mean ± SD. The statistical analysis was 
conducted using SPSS program. t-Test and χ2 test were performed 
to assess OE compared with WLE on detected lesions. Data were 
analyzed using the Mann-Whitney U test to compare group means. 
A p value less than 0.05 was considered to represent a significant 
difference.
Results
Patient’s Characteristics
The average age of patients at diagnosis was 53 years 
and ranged from 22 to 89 years. A total of 15 (60%) of the 
examined patients were female. The diagnosis of GERD 
was established in 14 (56%) patients. The control group 
consisted of 11 patients. 
IPCL Characterization
About 57% patients with GERD showed tortuosity in 
IPCLs when examined with OE, whereas the same feature 
was seen in only 1 out of the 11 controls (p = 0.042). Dila-
tion of the IPCLs was observed in 12 (86%) patients with 
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GERD. This feature was not seen in any of the patients in 
the control group (n = 0, p = 0.003). 
Furthermore, GERD patients had significantly in-
creased number of IPCLs at the esophagogastric junction 
in comparison to patients without reflux disease (12 vs. 1; 
p = 0.001). The main IPCL features in the study popula-
tion are summarized in Table 1.
In Figures 1 and 2, endoscopic images of all 3 IPCLs’ 
features (tortuosity, dilation, and vascularity) are depict-
ed during WLE and OE.
Vascularity and Mucosal Breaks
Using the OE system, the vascularization of the area 
above the Z-line could be thoroughly examined. We 
found a significant proportion of patients with GERD 
with an increased vascularity of this specific region 
(79%, n = 11). The respective proportion of patients in 
the control group showed an increased number of blood 
vessels in the observed region in 27% of patients (p = 
0.03). Moreover, 50% of patients with reflux symptoms 
showed mucosal breaks in the inspected areas. On the 
contrary, areas of slough or erythema could not be ob-
served in any of the patients in the control group (n = 0, 
p = 0.03). The main findings related to vascularity and 
mucosal breaks in the study population are summarized 
in Table 1.
Discussion
This is the first study showing the potential of the most 
recently introduced OE technology for the diagnosis of 
GERD. The OE technology significantly improved the 
 diagnosis of GERD compared to high-definition WLE, 
thereby potentially allowing for a better diagnosis and 
therapy of patients.
GERD is associated with a large social-economic bur-
den [15]. Furthermore, Barrett’s esophagus is a serious 
complication of GERD since it is considered a precursor 
for esophageal adenocarcinoma. Thus, the need for an ac-
curate and early diagnosis of GERD is of major impor-
tance [16]. However, the establishment of GERD diagno-
sis remains in most cases time consuming and challeng-
ing due to the absence of endoscopic findings. Even 
though 24-h esophageal pH monitoring is considered the 
gold standard for the confirmation of NERD, false-nega-
tive or false-positive results are common [17]. In a recent 
retrospective study 44% of patients with esophageal dys-
motility, 57% of patients with eosinophilic esophagitis, 
and 73% of patients with gastroparesis showed patholog-
ic acid reflux according to pH measures [18]. Further-
more, the benefit of histological examination for the di-
agnosis of NERD remains controversial, such that cur-
rent guidelines do not recommend biopsies from normal 
esophageal mucosa for this purpose [19]. In this context, 
current studies focus on the utility of new imaged en-
hanced endoscopy techniques to improve the low sensi-
tivity of conventional endoscopy for the diagnosis of 
GERD [20]. 
In the present study, the clinical utility of the OE sys-
tem in a group of patients with GERD and controls was 
assessed. We showed a significant increase in quantity, 
dilation, and tortuosity of IPCLs in patients with GERD. 
Our results suggest a distortion of the micro-vasculariza-
tion at the squamocolumnar junction, which cannot be 
detected using conventional WLE and is not present in 
Table 1. Distribution of endoscopic features using optical en-
hancement
Characteristic GERD, n (%) Control, n (%) p value
IPCL tortuocity 8 (57.1) 1 (0.09) 0.042
IPCL dilation 12 (85.7) 0 (0) 0.0003
IPCL increased 12 (85.7) 1 (0.09) 0.001
Increased vascularity 11 (78.6) 3 (27.3) 0.03
Visible mucosal breaks 7 (50) 0 (0) 0.03
IPCL, intrapapillary capillary loop.
Fig. 1. The Optical Enhancement technology utilizes optical filters 
in combination with digital post-processing for enhanced visual-
ization of surface and vascular changes.
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patients without reflux symptoms. Similar results have 
been reported by Sharma et al. [12] who examined 50 pa-
tients with GERD and 30 controls with NBI. They ob-
served an increased number, tortuosity, and dilatation of 
IPCLs in GERD patients (66, 80, and 80% respectively). 
Nevertheless, 14, 37, and 17% of controls showed in NBI 
similar microvascular alterations, whereas in our study 
these were almost absent in the control group. Increment 
and dilatation of IPCLs as characteristic features of GERD 
have also been reported in other trials using magnifying 
endoscopy and NBI [8, 13, 21]. In a recent trial of 20 pa-
tients with GERD and 60 controls, the same endoscopic 
findings were reported using either i-scan or NBI [22]. Lv 
et al. [13] detected, however, no significant difference in 
the presence of prolonged, dilated, or tortuous IPCLs, 
whereas Banerjee showed that IPCLs’ dilatation resolves 
under treatment with proton pump inhibitors, suggesting 
their role as possible predictors for NERD and response 
to treatment [8].
In the second part of our study, we investigated the 
utility of OE in identifying structural changes on the mu-
cosa of patients with GERD. We detected significant 
higher vascularization and mucosal breaks in GERD pa-
tients than in subjects without GERD. Previously, high-
resolution endoscopy and chromoendoscopy had been 
used in GERD patients to evaluate findings not visualized 
by WLE [23, 24]. It has been reported [23] that subtle en-
doscopic findings such as vascular injection or vascular 
spots above the Z-line, villous mucosal surface, and is-
lands of squamous cell epithelium below the Z-line are 
criteria of a minimal change esophagitis in patients with 
GERD. 
Similar minimal changes in the squamocolumnar 
junction of the esophagus have been reported in other 
studies comparing the utility of i-scan, FICE with that of 
WLE [6, 7, 25–28]. In all these trials, image-enhanced en-
doscopy increased the diagnostic yield of reflux esopha-
gitis by detecting, in accordance with our results, mucosal 
and vascular alterations at the distal esophagus adjacent 
to the Z-line. However, in a study by Kim et al. [29] in 
1,445 patients, the prevalence of minimal change esopha-
gitis was not significantly different between patients with 
GERD and patients without GERD suggesting reconsid-
eration of their clinical significance. 
To the best of our knowledge, this is the first prospec-
tive trial evaluating the diagnostic utility of OE in patients 
with benign esophageal diseases such as GERD. Kodashi-
ma et al. [30] has shown that OE can improve the detec-
tion and characterization of esophageal squamous cell 
cancer. The OE technology uses wavelengths that corre-
spond to the peaks of the hemoglobin absorption spec-
trum as the main wavelength of the illumination light. 
Due to its high illumination intensity, it provides addi-
tional information for the microvascular patterns also in 
organs with a large lumen. 
This study has certain limitations. First, it was a single-
center study which was conducted at a tertiary referral 
institution. Also, it was an unblinded pilot trial; therefore, 
an operator bias cannot be excluded. In addition, no 24-h 
pH monitoring was performed in the patient cohort con-
sidered. Therefore, there might be a cross contamina-
tion  that supposedly reflects the few controls which 
showed increased vascularity, tortuosity, and an increase 
in IPCLs. Nevertheless, esophageal pH monitoring has 
Fig. 2. Optical Enhancement combined with optical magnification imaging reveals subtle details in patients with 
GERD. Dilation and an increased number of intrapapillary capillary loops were more often identified in GERD 
patients compared to controls.
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limitations of its own, which include inadequate sensitiv-
ity, especially in the milder forms of GERD. At last, al-
though a prospective inclusion was performed, no sample 
size calculation was done due to the novelty of the OE 
technology. The number of patients who participated in 
our study was based on the clinical presentation of pa-
tients in our endoscopy department during a period of 
approximately 1 year. Further studies can now use the 
results of the present study to conduct an adequate statis-
tical workout. 
Recent advances in endoscopic imaging have been 
made in an effort to improve the detection of esophageal 
diseases. However, whether such advances have im-
proved the detection of esophageal pathologies com-
pared to conventional high-definition WLE is still under 
debate. We have shown for the first time that OE has a 
significant additional effect in distinguishing the mini-
mal vascular and structural changes in GERD compared 
with WLE. However, further multicenter trials are neces-
sary to evaluate the diagnostic utility of OE in patients 
suffering from GERD, as well to compare its diagnostic 
accuracy with that of other advanced imaging tech-
niques. 
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